Research Use Only - Not for human consumption. 18+ only.

Ipamorelin vs GHRP-2

Evidence-based comparison · Updated 2026

Summary

Ipamorelin is generally preferred for clean, selective GH release with minimal side effects, making it suitable for long-term use focused on body composition, recovery, and anti-aging. GHRP-2 produces a stronger GH pulse and also stimulates appetite, making it more relevant for aggressive muscle-building or cases where appetite stimulation is a goal. Choose Ipamorelin for tolerability and selectivity; choose GHRP-2 for potency and appetite effects.

Side-by-Side Comparison

IpamorelinGHRP-2
EvidenceCGrade CPrimarily animal or in-vitro studies; limited human dataCGrade CPrimarily animal or in-vitro studies; limited human data
RegulatoryCompoundableCompoundableLegal to compound in the US; approved in other jurisdictions or has historical approvalCompoundableCompoundableLegal to compound in the US; approved in other jurisdictions or has historical approval
Benefits
  • +Stimulates growth hormone release
  • +Minimal effect on cortisol and prolactin
  • +Supports lean muscle mass development
  • +Aids in fat metabolism and anti-aging
  • +Improves sleep quality
  • +Potent GH secretagogue
  • +Increases appetite
  • +Promotes muscle growth
  • +Enhances recovery
  • +Improves sleep quality
Dosage200-300 mcg mcg — 1-3x daily100-300 mcg mcg — 2-3x daily
RouteSubcutaneousSubcutaneous
CategoryGrowth Hormone SecretagoguesGrowth Hormone Secretagogues

Which Should You Choose?

Both peptides act as GHS-R1a agonists to stimulate endogenous GH release, but GHRP-2 additionally inhibits somatostatin and elevates cortisol and prolactin more significantly, while Ipamorelin is highly selective for GH secretion with minimal off-target hormonal activity.

Choose Ipamorelin when:

  • +You want selective GH stimulation with minimal cortisol or prolactin elevation, reducing the risk of stress-hormone-related side effects
  • +Your primary goals are fat metabolism, lean muscle maintenance, improved sleep, or anti-aging rather than aggressive muscle hypertrophy
  • +You are planning extended-duration use and prioritize a cleaner hormonal profile over maximum GH pulse amplitude

Choose GHRP-2 when:

  • +You require a more potent GH pulse and are willing to accept modestly elevated cortisol and prolactin as a trade-off
  • +Appetite stimulation is a desired outcome, such as in recovery from illness, underweight conditions, or caloric surplus phases
  • +Short-term, goal-specific protocols where maximum GH secretagogue potency takes priority over hormonal selectivity

Stacking Ipamorelin with a GHRH analog such as CJC-1295 is more common than combining it with GHRP-2 directly, though some research protocols have paired GHRP-2 with GHRH analogs to amplify GH output; combining Ipamorelin and GHRP-2 together is less conventional given their overlapping receptor targets and the added cortisol burden introduced by GHRP-2.

Frequently Asked Questions

Does combining Ipamorelin and GHRP-2 produce a greater GH response than either peptide alone?
Because both peptides act on the same GHS-R1a receptor, their co-administration may produce diminishing additive returns compared to pairing either peptide with a GHRH analog, which works through a complementary receptor pathway. Preclinical data suggest that GHRH plus a GHS-R1a agonist yields synergistic GH amplification, whereas two GHS-R1a agonists administered together tend to show less synergy. From a risk-benefit standpoint, stacking GHRP-2 with Ipamorelin also compounds the cortisol and prolactin elevation attributable to GHRP-2.
How do the side effect profiles of Ipamorelin and GHRP-2 differ, and does that affect which to choose?
Ipamorelin's primary advantage is its selectivity: research consistently shows it produces negligible increases in cortisol or prolactin relative to the GH response it generates. GHRP-2, by contrast, measurably elevates both cortisol and prolactin alongside GH, which may be relevant for individuals sensitive to these hormones or using the peptide over longer periods. For users prioritizing minimal hormonal disruption outside the GH axis, Ipamorelin's cleaner profile makes it the more conservative choice.
Which peptide produces results on a faster timeline, Ipamorelin or GHRP-2?
GHRP-2 tends to generate a larger acute GH pulse, so users may notice earlier appetite stimulation and potentially faster short-term anabolic signaling. Ipamorelin produces a more modest but still physiologically meaningful GH release that aligns closely with the body's natural pulsatile pattern, which may support more gradual and sustained changes in body composition over weeks to months. Neither peptide has been studied in direct head-to-head clinical trials quantifying time-to-outcome differences in humans.
If my goal is improved sleep and recovery rather than muscle growth, is Ipamorelin or GHRP-2 the better option?
Both peptides have been associated with improved sleep quality in research contexts, likely because endogenous GH secretion is closely tied to slow-wave sleep architecture. However, Ipamorelin's selectivity and lower side-effect burden make it the more commonly cited option in protocols targeting sleep and recovery specifically, since the cortisol elevation associated with GHRP-2 could theoretically work against sleep quality and recovery at higher doses. Evidence for both remains at a preclinical or small-study level, so neither can be formally recommended over the other based on current data.

Not sure which fits your research goals?

Use the Goal Finder

Answer 3 questions and get a personalised peptide recommendation ranked by evidence grade.

Find My Peptide →